|Day Low/High||47.78 / 54.77|
|52 Wk Low/High||39.21 / 105.99|
Worries are increasing around the industry, though Visteon remains a stock to watch.
The market is off to a decent start as investors try to digest scores of first-quarter earnings reports. Bristol-Myers Squibb is just one of many large-cap drug and biotech companies reporting today. BMY shares are up as earnings and revenue easily ...
As the Trump rally gets dinged, I have started to accumulate a new position.
The longer view of the stock shows a great uptrend and lengthy consolidation.
This stock offers exposure to higher auto and truck sales, says Portfolio Manager David Peltier.
Portfolio manager David Peltier discusses the recent sales trends at this low-dollar automaker.